Nasal Drug Delivery Mode Market, By Therapeutic Application (Asthma, Rhinitis, and Others), By Dosage Form (Powder, Gel. Spray, and Gel), By Container Type (Pressurized Container, Non Pressurized, and Container), By System Type (Multi- Dose, Bi-Dose, and

Nasal Drug Delivery Mode Market, By Therapeutic Application (Asthma, Rhinitis, and Others), By Dosage Form (Powder, Gel. Spray, and Gel), By Container Type (Pressurized Container, Non Pressurized, and Container), By System Type (Multi- Dose, Bi-Dose, and Unit Dose), By End Users (Hospitals and Homecare Settings), By Distribution (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Drug delivery refers to the technology utilized to present the drug to the desired body site for drug release and absorption. Intranasal drug delivery offers a rapid onset of therapeutic effects (local or systemic). Nasal applications of topical decongestants or anti-inflammatory drugs are most popular topical nasal drug deliveries. Nasal delivery is the logical choice for treatment of diseases in the nose and paranasal sinuses. Over the years, nasal route has gained widespread interest as a promising and an alternative route to oral and parenteral drug delivery.

Market Dynamics:

Growing prevalence of asthma and chronic obstructive pulmonary disease (COPD), increasing adoption of self-administration practices, and increasing preference for nasal drug delivery are some major factors expected to boost the growth of the global nasal drug delivery mode market over the forecast period. Asthma is a major noncommunicable disease (NCD) that affects both children and adults. For instance, according to the Asthma and Allergy Foundation of America (AAFA), more than 25 million people in the U.S. have asthma, about 1 in 13 people. Moreover, over 20 million adults aged 18 and older have asthma in the U.S., and asthma rates are highest in Black adults in the United States.

Key features of the study:

  • This report provides in-depth analysis of the global nasal drug delivery mode market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021 to 2028), considering 2020 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the nasal drug delivery mode market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck & Co., Inc., Astra Zeneca, GlaxoSmithKline Plc, Mystic Pharmaceuticals, PendoPharm Inc., Bausch Health, 3M, Cadila Pharmaceuticals, Optinose, Dr. Reddy Laboratories, Neurelis Inc., Aptar Group, Johnson & Johnson Services Inc., ENT Technologies Pty Ltd., and Becton, Dickinson and Company, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global nasal drug delivery mode market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal drug delivery mode market.
Detailed Segmentation:
  • Global Nasal Drug Delivery Mode Market, By Therapeutic Application:
  • Asthma
  • Rhinitis
  • Others
  • Global Nasal Drug Delivery Mode Market, By Dosage Form:
  • Powder
  • Gel
  • Spray
  • Gel
  • Global Nasal Drug Delivery Mode Market, By Container Type:
  • Pressurized Container
  • Non Pressurized
  • Container
  • Global Nasal Drug Delivery Mode Market, By System Type:
  • Multi- Dose
  • Bi-Dose
  • Unit Dose
  • Global Nasal Drug Delivery Mode Market, By End Users:
  • Hospitals
  • Homecare Settings
  • Global Nasal Drug Delivery Mode Market, By Distribution:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Nasal Drug Delivery Mode Market, By Region:
  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East
  • Africa


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Nasal Drug Delivery Mode, By Therapeutic Application
Market Nasal Drug Delivery Mode, By Dosage Form
Market Nasal Drug Delivery Mode, By Container Type
Market Nasal Drug Delivery Mode, By System Type
Market Nasal Drug Delivery Mode, By End Users
Market Nasal Drug Delivery Mode, By Distribution
Market Nasal Drug Delivery Mode, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increase in adoption of self-administration practices
Stringent rules and regulations
Outbreak of COVID-19 (pandemic)
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Nasal Drug Delivery Mode Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Nasal Drug Delivery Mode Market, By Therapeutic Application, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Asthma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Rhinitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
6. Nasal Drug Delivery Mode Market, By Dosage Form, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Powder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Spray
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Gel
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
7. Nasal Drug Delivery Mode Market, By Container Type, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Pressurized Container
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Non-Pressurized Container
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
8. Nasal Drug Delivery Mode Market, By System Type, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Multi-Dose
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Bi-Dose
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Unit Dose
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
9. Nasal Drug Delivery Mode Market, By End User, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Homecare Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
10. Nasal Drug Delivery Mode Market, By Distribution, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
11. Nasal Drug Delivery Mode Market, By Region, 2021 to 2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Middle East and Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Rest of World
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
12. Competitive Landscape
Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline Plc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Astra Zeneca
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Johnson & Johnson Services Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Mystic Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bausch Health
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
PendoPharm Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Optinose
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Cadila Pharmaceutical s Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
3M
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Reddy Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Aptar Group Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Neurelis Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
ENT Technologies Pty Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Becton, Dickinson and Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
13. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Global Nasal Drug Delivery Mode Market” - forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings